Cited by 228Obstructive Sleep Apnea ResearchSleep and related disordersApelin-related biomedical research

Obstructive Sleep Apnea and Cardiovascular Disease

Pack, Allan I., Gislason, Thorarinn·2009·Progress in Cardiovascular Diseases

Abstract

Data from animal and human studies provide a biological plausibility to the notion that obstructive sleep apnea activates pathways that lead to insulin resistance, atherosclerosis and hypertension. Sleep apnea thus activates the same pathways as does obesity. That obstructive sleep apnea is a risk factor for cardiovascular disease is supported by epidemiological association studies. Longitudinal cohort studies also provide evidence that patients with untreated severe sleep apnea have an increased rate of cardiovascular events. But these studies, while highly suggestive, do not provide the evidence needed to convince the skeptic. This would only be obtained by randomized treatment trials with hard cardiovascular endpoints such as cardiac events and deaths. While such studies are in the planning stages, they will be challenging. There are issues about randomizing individuals with severe sleep apnea and excessive sleepiness into no therapy, since they are at known increased risk for car crashes. Thus, lack of therapy puts others on the road at risk as well as the subject with sleep apnea. There is, moreover, the concern that treating obstructive sleep apnea in very obese individuals will have little impact, since any effect of therapy for OSA will be overwhelmed by the effects of obesity itself. Data from randomized treatment trials for cardiovascular endpoints will likely not be available for many years. In the interim, physicians need to consider how to treat such patients. It is proposed that given that CPAP treatment for obstructive sleep apnea is highly effective and essentially totally safe, and that the evidence is suggestive that sleep apnea is a risk factor for cardiovascular disease, then we propose all patients with severe sleep apnea should be treated to reduce cardiovascular risk.

Integrity signals

Registry

Crossref · 10.1016/j.pcad.2009.01.002

Cites

170 of 170 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pack, A. I., & Gislason, T.
Affiliations
University of Pennsylvania (US)
Corresponding author
Pack, Allan I.
Venue
Progress in Cardiovascular Diseases
Publisher
Elsevier BV
Published
2009-03
Volume
51
Issue
5
Pages
434-451
ISSN
0033-0620 (ISSN-L)
OpenAlex
W2153423639
Cited by
228
References
170
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 9 · 2022: 6 · 2021: 11 · 2020: 8 · 2019: 9 · 2018: 12 · 2017: 18 · 2016: 20 · 2015: 19 · 2014: 22 · 2013: 20 · 2012: 22
FWCI
14.19
Type
journal article
Language
en
Open access
closed
Locations
  • Progress in Cardiovascular Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Pharmacology › Apelin-related biomedical research
Keywords
obstructive sleep apnea, cardiovascular disease, cardiovascular risk, insulin resistance, atherosclerosis, hypertension, obesity, CPAP therapy, traffic accidents, excessive daytime sleepiness
MeSH terms
Animals, Hypoxia, Cardiovascular Agents, Cardiovascular Diseases, Disease Models, Animal, Hemodynamics, Humans, Hypertension, Insulin Resistance, Obesity, Risk Factors, Snoring, Sympathetic Nervous System, Epidemiologic Research Design, Randomized Controlled Trials as Topic, Treatment Outcome, Oxidative Stress, Patient Selection, Evidence-Based Medicine, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review